News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
259
Sources here
19
Companies here
5
Search results Stored financial headlines

Active search

259 matching headlines

Ticker or company: QUESTMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Quest Resource Holding Corporation Reports Second Quarter 2026 Financial Results

Quest Resource Holding Corporation (QRHC) reported a 7.6% increase in Q2 2026 revenue to $64.1 million, driven by new customer wins and wallet share expansions. Despite a GAAP net loss of $(12.2) million due to a non-cash goodwill impairment, Adjusted EBITDA grew to $2.8 …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Aquestive Therapeutics, Inc. (AQST) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aquestive Therapeutics, Inc. (NASDAQ:AQST) securities. The investigation focuses on whether Aquestive officers and/or directors engaged in corporate wrongdoing, particularly for investors who purchased shares before June 16, 2025, and still …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC

Empowered Funds LLC significantly reduced its stake in Quest Diagnostics (NYSE:DGX) by 61.5% in the first quarter, selling over 15,000 shares. Despite this, institutional investors still own a substantial 88.06% of the company's stock. Quest Diagnostics exceeded Q1 earnings and revenue expectations, and analysts …

DGX main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource Holding Corp Q2 2026: Revenue $64.07M, EPS $(0.57) — 10-Q Summary

Quest Resource Holding Corp (QRHC) reported its second-quarter 2026 results, showing a revenue increase to $64.07 million, up 7.6% year-over-year. Despite the revenue growth, the company recorded a net loss of $12.22 million and a diluted loss per share of $(0.57), primarily due to …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HireQuest, Inc. (HQI) Q1 2023 Earnings Report - Results, Call & Slides

HireQuest, Inc. (HQI) reported its Q1 2023 earnings, missing consensus EPS estimates with an actual EPS of $0.19 against an expected $0.28. However, the company beat revenue expectations, achieving $9.86M against a projected $9.62M, marking a 21.02% year-over-year revenue growth. The earnings call was …

HQI main company
Sharemaestro market context Trend signal active 52 weeks +75.6% HQI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource Holding Corp (QRHC) (Q2 2026) Earnings Call Highlights: Returns to Growth with ...

Quest Resource Holding Corp (QRHC) reported a return to revenue and adjusted EBITDA growth in Q2 2026, with revenue up 8% year-over-year. The company diversified its client base, reduced SG&A by 11%, and generated strong operating cash flow of $4.5 million, contributing to debt …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource Holding posts Q2 2026 revenue up 7.6% to $64.1M; Adjusted EBITDA $2.8M

Quest Resource Holding reported a 7.6% year-over-year increase in Q2 2026 revenue, reaching $64.1 million, with an Adjusted EBITDA of $2.8 million. Despite a GAAP net loss of $(12.2) million due to an $11.0 million goodwill impairment, the company achieved $4.5 million in operating …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource reports $4.5M operating cash flow, voluntary $2M term-debt cut

Quest Resource Holding Corporation (NASDAQ: QRHC) announced its Q2 2026 financial results, reporting a 7.6% increase in revenue to $64.1 million and Adjusted EBITDA of $2.8 million. Despite a GAAP net loss of $12.2 million due to an $11.0 million non-cash goodwill impairment, the …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource: Q2 Earnings Snapshot

Quest Resource Holding Corp. reported a Q2 net loss of $12.2 million, or 57 cents per share. Adjusted for asset impairment costs, the loss was 5 cents per share. The recycling company also announced revenue of $64.1 million for the quarter.

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Shares of Quest Diagnostics Inc. rose 1.13% to $238.50 on a strong trading day, outperforming the S&P 500 Index and the Dow Jones Industrial Average, both of which experienced declines. This marks the third consecutive day of gains for the stock.

DGX main company QUEST main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Preview: AQST to Report Financial Results Post-market on August 11

AQST is scheduled to announce its financial results after the market closes on August 11. Investors will be closely watching the earnings report for insights into the company's performance and future outlook. This preview serves as a heads-up for those tracking AQST's financial news.

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arrowstreet Capital Limited Partnership Purchases New Shares in Quest Diagnostics Incorporated $DGX

Arrowstreet Capital Limited Partnership initiated a new position in Quest Diagnostics (NYSE:DGX) by acquiring 11,468 shares valued at approximately $2.25 million. This move comes as institutional investors now own 88.06% of the company, and several analysts have raised price targets following Quest Diagnostics' strong …

DGX main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Quest Diagnostics (DGX) A Bargain Following Raised Guidance And Strong Quarterly Results?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Quest Diagnostics (DGX) has drawn fresh attention after raising its full year 2026 revenue and earnings guidance, alongside reporting second quarter results that showed …

DGX main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Diagnostics (DGX) Stock May Be 32% Undervalued As Guidance Rises

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Quest Diagnostics stock has climbed strongly over the past few years, yet current valuation checks suggest the shares may still trade below an estimate …

DGX main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource (QRHC) grants 2,755 RSUs to director Glenn Culpepper

Quest Resource Holding Corp director Glenn Culpepper was granted 2,755 restricted stock units (RSUs) on July 31, 2026, at a price of $1.27 per share, under the company's 2024 Incentive Compensation Plan. These RSUs are scheduled to vest on March 1, 2027. The filing …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

2,755 RSU grant adds to Quest Resource (QRHC) director's equity stake

Quest Resource Holding Corp director Stephen A. Nolan received a grant of 2,755 restricted stock units (RSUs) on July 31, 2026, under the 2024 Incentive Compensation Plan, valued at $1.27 per share. These RSUs are scheduled to vest on March 1, 2027, increasing his …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource (QRHC) director granted 2,755 RSUs, boosting total holdings to 56,998

Robert J. Lipstein, a director at Quest Resource Holding Corp (QRHC), was granted 2,755 restricted stock units (RSUs) on July 31, 2026, under the company's 2024 Incentive Compensation Plan. These RSUs, valued at $1.27 per share, are set to vest on March 1, 2027. …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Resource Holding Corp (QRHC) director reports 21,984-unit RSU grant

Daniel M. Friedberg, a director at Quest Resource Holding Corp (QRHC), reported a grant of 21,984 restricted stock units (RSUs) on July 31, 2026, priced at $1.27 per unit, under the 2024 Incentive Compensation Plan. These RSUs are set to vest on March 1, …

QRHC main company
Sharemaestro market context Price above Trend Line 52 weeks -4.8% QRHC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Aquestive Therapeutics, Inc. (NASDAQ:AQST) and certain officers. The lawsuit alleges that Aquestive Therapeutics made materially false and misleading statements regarding the approval timeline for its drug Anaphylm, specifically related to human factors …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates

Quest Diagnostics (DGX) has increased its 2026 revenue and adjusted earnings guidance, attributing the improved outlook to accelerated testing demand across various channels. While the company's Q2 results exceeded expectations, driven by volume growth, concerns remain regarding the impact of lower-margin partnerships and increased …

DGX main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Aquestive Therapeutics, Inc. (AQST) And Encourages Stockholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating Aquestive Therapeutics, Inc. (NASDAQ:AQST) for potential corporate wrongdoing. The firm encourages stockholders who purchased Aquestive securities before June 16, 2025, and still hold them, to contact them to assist in the investigation. The firm operates on a …

AQST main company
Sharemaestro market context Price above Trend Line 52 weeks +6.8% AQST stored weekly price path from 22 Aug 2025 to 14 Aug 2026

HireQuest Number of Employees 2026 | Employee Count & Headcount Data

HireQuest, Inc. (HQI) had approximately 76,051 total employees worldwide as of March 2026, representing a 0.1% growth from 2023. The company is actively hiring with 358 active job postings in 2026, despite a significant decline in job postings from 2025. The workforce is primarily …

HQI main company
Sharemaestro market context Trend signal active 52 weeks +75.6% HQI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context